Arrhythmias and Cardiac Electrophysiology, Ospedale San Raffaele, Milan, Italy.
Electrophysiology Lab, Clinica Montevergine, Mercogliano (AV), Italy.
JACC Clin Electrophysiol. 2019 Oct;5(10):1197-1208. doi: 10.1016/j.jacep.2019.06.018. Epub 2019 Aug 28.
This study evaluated the temporal association between atrial high-rate episodes (AHREs) and sustained ventricular arrhythmias (VAs) in a remotely monitored cohort with implantable cardioverter-defibrillators (ICD) with and/or without cardiac resynchronization therapy with a defibrillator (CRT-D).
Clinical relevance of AHREs in terms of VA rate and survival has not been outlined yet.
This study analyzed data of patients with ICDs and CRT-Ds from the nationwide Home Monitoring Expert Alliance network. The cohort included 2,435 patients with a median follow-up of 25 months (interquartile range: 13 to 42 months) and age 70 years (range 61 to 77 years); 19.7% were women, 51.4% had coronary artery disease, and 45.2% had a CRT-D. There were 3,410 appropriate VA episodes; 498 (14.6%) were preceded by AHREs within 48 h; in 85.5% of this group, AHREs were still ongoing at episode onset.
In a longitudinal analysis, the odds ratios (ORs) of experiencing any VA in a 30-day interval with AHREs versus intervals without AHREs were 2.35 (95% confidence interval [CI]: 1.86 to 2.97; p < 0.001) for ventricular tachycardia (VT), 3.06 (95% CI: 2.35 to 3.99; p < 0.001) for fast VT, 1.84 (95% CI: 1.36 to 2.48; p < 0.001) for self-extinguishing ventricular fibrillation (VF), and 2.31 (95% CI: 1.17 to 4.57; p = 0.01) for VF. ORs decreased with increasing AHRE burden. Patients with AHREs 48 h before VAs were more likely to experience VA recurrences (adjusted hazard ratio [HR]: 1.78; 95% CI: 1.41 to 2.24; p < 0.001) and had higher overall mortality (HR: 2.67; 95% CI: 1.68 to 4.23; p < 0.001).
AHREs were not uncommon 48 h before VAs, which tended to be distributed around intervals with AHREs. Temporal connection between AHREs and VAs was a marker of increased risk of VA recurrence and a poorer prognosis.
本研究评估了植入式心律转复除颤器(ICD)伴或不伴心脏再同步治疗除颤器(CRT-D)的远程监测队列中,心房高频事件(AHREs)与持续性室性心律失常(VA)之间的时间关联。
AHREs 在 VA 发生率和生存率方面的临床意义尚未阐明。
本研究分析了全国性家庭监测专家联盟网络中 ICD 和 CRT-D 患者的数据。该队列纳入了 2435 例患者,中位随访时间为 25 个月(四分位间距:13 至 42 个月),年龄 70 岁(范围 61 至 77 岁);19.7%为女性,51.4%患有冠状动脉疾病,45.2%植入 CRT-D。共发生 3410 次适当的 VA 事件;498 次(14.6%)在 48 小时内发生 AHREs 之前;在该组中,85.5%的患者在事件发生时仍存在 AHREs。
在纵向分析中,与无 AHREs 间隔相比,在 30 天间隔内出现 AHREs 的任何 VA 的优势比(OR)为:室性心动过速(VT)为 2.35(95%置信区间[CI]:1.86 至 2.97;p<0.001),快速 VT 为 3.06(95%CI:2.35 至 3.99;p<0.001),自限性心室颤动(VF)为 1.84(95%CI:1.36 至 2.48;p<0.001),VF 为 2.31(95%CI:1.17 至 4.57;p=0.01)。OR 随 AHRE 负担的增加而降低。VA 发生前 48 小时存在 AHREs 的患者更有可能发生 VA 复发(校正后危险比[HR]:1.78;95%CI:1.41 至 2.24;p<0.001),且总体死亡率更高(HR:2.67;95%CI:1.68 至 4.23;p<0.001)。
AHREs 在 VA 发生前 48 小时并不罕见,且往往分布在 AHRE 间隔内。AHREs 与 VA 之间的时间关联是 VA 复发风险增加和预后较差的标志。